Breaking News

ADC Bio Expands

Will invest $10m in cancer drug production

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

UK-based ADC Biotechnology has announced a $10 million plan to build a 1,500 square-meter manufacturing facility for advanced anti-cancer drugs. The two-stage expansion program marks the transition of ADC Bio into GMP manufacturing of ADCs (antibody drug conjugates) and will create over 60 new science jobs at completion. The investment responds to demand by drug developers and a shortage of capacity to make these new drugs in quantities sufficient for large-scale clinical trials. Phase ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters